Rare Cancers Clinical Trials in Heidelberg
2 recruitingHeidelberg, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 4
Dabrafenib and/or Trametinib Rollover Study
MelanomaNon-small Cell Lung CancerSolid Tumor+2 more
Novartis Pharmaceuticals100 enrolled28 locationsNCT03340506
Recruiting
Molecularly Aided Stratification for Tumor Eradication Research
MultiomicsRare Cancers
German Cancer Research Center10,000 enrolled1 locationNCT05852522